Receptor-Guided Nanomedicine for Rheumatoid Arthritis: Linking Target Biology, Nanocarrier Design, and Translation.
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent synovitis and progressive joint destruction. Although current therapies improve disease control, inadequate lesion selectivity, heterogeneous responses, and systemic toxicity remain important limitations. Receptor-guided nanomedicine...